-
1.
Kasiske BL, Chakkera HA, Louis TA, Ma JZ: A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11(10):1910–7.
-
2.
Pascual J, Quereda C, Zamora J, Hernandez D: Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transpl 2004; 78(10):1548–56.
-
3.
Ahsan N, Hricik D, Matas A, Rose S, Tomlanovich S, Wilkinson A, et al..: Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil—a prospective randomized study. Steroid Withdrawal Study Group. Transpl 1999; 68(12):1865–74.
-
4.
Vanrenterghem Y, Lebranchu Y, Hene R, Oppenheimer F, Ekberg H: Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transpl 2000; 70(9):1352–9.
-
5.
Cole E, Landsberg D, Russell D, Zaltzman J, Kiberd B, Caravaggio C, et al..: A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transpl 2001; 72(5):845–50.
-
6.
Elias TJ, Bannister KM, Clarkson AR, Russ GR, Mathew TH, Barratt LJ, et al..: Excellent long-term graft survival in low risk, primary renal allografts treated with prednisolone-avoidance immunosuppression. Clin Transpl 2000; 14(2):157–61.
-
7.
Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O, Jr.: Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transpl 2003; 76(9):1331–9.
-
8.
Shapiro R, Ellis D, Tan HP, Moritz ML, Basu A, Vats AN, et al..: Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr 2006; 148(6):813–8.
-
9.
Matas AJ, Kandaswamy R, Gillingham KJ, McHugh L, Ibrahim H, Kasiske B, et al..: Prednisone-free maintenance immunosuppression—a 5-year experience. Am J Transpl 2005; 5(10):2473–8.
-
10.
Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A: Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transpl 2003; 3(3):306–11.
-
11.
Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J: A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transpl 2008; 8(2):307–16.
-
12.
Meier-Kriesche HU, Magee JC, Kaplan B. Trials and tribulations of steroid withdrawal after kidney transplantation. Am J Transpl 2008; 8(2):265–6.
-
13.
Hricik DE. Comparing early withdrawal or avoidance of steroids with standard steroid therapy in kidney transplant recipients. Nat Clin Pract Nephrol 2008; 4(7):360–1.
-
14.
Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P: A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008; 248(4):564–77.
-
15.
McDonald RA, Smith JM, Ho M, Lindblad R, Ikle D, Grimm P, et al..: Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transpl 2008; 8(5):984–9.
-
16.
Pascual J, Zamora J, Galeano C, Royuela A, Quereda C: Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009; (1):CD005632.
-
17.
Humar A, Gillingham K, Kandaswamy R, Payne W, Matas A: Steroid avoidance regimens: a comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode. Am J Transpl 2007; 7(8):1948–53.
…But Not All Patients Should be Steroid-Free Posttransplant
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory